Biodock

Making deep AI easy to train on biological images.

About

Founded

2020

Headquarters

Austin, Texas

Industry

Biotech, Artificial Intelligence (AI)

Company Description

Pharmaceutical scientists spend thousands of hours on microscopy image analysis. Biodock’s AI platform automates that work to minutes.

Quick Links

WebsiteJobs

Funding

Total Raised

$2.1 million

Valuation

Undisclosed

Significant Investors

Andreessen Horowitz, TQ Ventures, Soma Capital

Company Traction

  • As of March 2021, scientists at 100+ organizations use Biodock, including Vaxxas, Genentech, CSL Behring, PIC Therapeutics, Dewpoint Therapeutics, and Arvinas.
  • As of March 2021, Biodock reports its modules are 50% more accurate than other software solutions.

Leadership Team

  • Michael Lee: Co-Founder & CEO of Biodock. Former Deep Learning Researcher at Stanford University School of Medicine.

Press